|
GPAM expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.34399999999857E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.360630E-04 |
| Normal-vs-Stage2 |
5.201300E-04 |
| Normal-vs-Stage3 |
5.056500E-03 |
| Normal-vs-Stage4 |
2.175300E-03 |
| Stage1-vs-Stage2 |
9.826800E-01 |
| Stage1-vs-Stage3 |
9.752000E-01 |
| Stage1-vs-Stage4 |
8.004600E-01 |
| Stage2-vs-Stage3 |
9.842800E-01 |
| Stage2-vs-Stage4 |
8.238600E-01 |
| Stage3-vs-Stage4 |
8.878200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.52123999999088E-05 |
| Normal-vs-AfricanAmerican |
1.322160E-01 |
| Normal-vs-Asian |
6.318800E-03 |
| Caucasian-vs-AfricanAmerican |
4.110600E-01 |
| Caucasian-vs-Asian |
7.689600E-01 |
| AfricanAmerican-vs-Asian |
3.223400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.93589999995115E-07 |
| Normal-vs-Female |
1.655750E-01 |
| Male-vs-Female |
3.790000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.80589999954073E-07 |
| Normal-vs-Extreme_Weight |
6.52909999954154E-07 |
| Normal-vs-Obese |
4.809500E-02 |
| Normal-vs-Extreme_Obese |
7.010800E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.982200E-01 |
| Normal_Weight-vs-Obese |
1.121790E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.410200E-01 |
| Extreme_Weight-vs-Obese |
1.235180E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.467800E-01 |
| Obese-vs-Extreme_Obese |
4.831800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.172330E-02 |
| Normal-vs-Age(41-60Yrs) |
4.244300E-03 |
| Normal-vs-Age(61-80Yrs) |
9.56020000000279E-05 |
| Normal-vs-Age(81-100Yrs) |
2.24889995514843E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.462200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.385200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.256600E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.398400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.5897199999948E-05 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.960740E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.48969999999682E-05 |
| Normal-VS-Type2 PRCC |
2.77659994996071E-09 |
| Normal-VS-KIRP CIMP |
6.998200E-02 |
| Normal-VS-Unclassified PRCC |
1.043820E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.441500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.369400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.745200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.058500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.273600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.650400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.49900003520997E-09 |
| Normal-vs-N1 |
1.949900E-02 |
| Normal-vs-N2 |
9.519900E-03 |
| N0-vs-N1 |
8.082200E-02 |
| N0-vs-N2 |
9.624000E-01 |
| N1-vs-N2 |
4.712800E-01 |
|
|
